Keywords: altair, unveils, renagel, fosrenol, rival, company, nanotechnologies

Altair unveils Renagel, Fosrenol rival

Article | 22 July 2002

Print This

US company Altair Nanotechnologies has revealed that it is developing anew agent for the treatment of elevated phosphate levels in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in